Form 4 for PHAT Phathom Pharmaceuticals, Inc.
Accepted 2024-01-25 00:00:00 ET · period of report 2024-01-24 · accession 0001395064-24-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-25 | 2024-01-24 | PHAT | TAKEDA PHARMACEUTICAL CO LTD | 10% | S - Sale | $8.10 | -3.70M | 3.76M | -50% | -$30.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-24 | S | D | 3,703,703 | $8.10 | 3,755,583 | D | — | — |